X0508 4 2025-12-22 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001509688 Schorno Dean L RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 true EVP & Chief Financial Officer false Common Stock 2025-12-22 4 M 0 1987 20 A 59722 D Common Stock 2025-12-22 4 M 0 2846 24.2 A 62568 D Common Stock 2025-12-22 4 M 0 1667 18.7 A 64235 D Employee Stock Option (right to buy) 20 2025-12-22 4 M 0 1987 0 D 2029-01-23 Common Stock 1987 14262 D Employee Stock Option (right to buy) 24.2 2025-12-22 4 M 0 2846 0 D 2030-02-06 Common Stock 2846 17153 D Employee Stock Option (right to buy) 18.7 2025-12-22 4 M 0 1667 0 D 2033-01-26 Common Stock 1667 10832 D These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. Includes 500 shares of common stock acquired under the Issuer's stock purchase plan. The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019, subject to the reporting person's continuous service to the Issuer through each such period. The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the Issuer through each such period. The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer through each such period. /s/ Raymond Furey (Attorney-in-Fact) 2025-12-29